You are viewing the site in preview mode
Skip to main content
|
Characteristics
|
Number of patients (%)
|
|---|
|
Age (years), mean ± SD
|
58.3 ± 9.5
|
|
Sex
|
|
Female
|
22 (42.3%)
|
|
Male
|
30 (57.7%)
|
|
Surgery
|
|
Biopsy
|
20 (38.4%)
|
|
Resection
|
32 (61.6%)
|
|
Karnofsky performance score
|
|
≥ 80%
|
45 (86.5%)
|
|
≥ 70 to < 80%
|
6 (11.5%)
|
|
< 70%
|
1 (2%)
|
|
Tumor Characteristics
|
|
Volume at baseline, mean ± SD
|
|
T1-weighted with Gadolinium W/necrosis
|
31.1 cm3 ± 28.6
|
|
T1-weighted with Gadolinium W/O necrosis
|
18 cm3 ± 16.5
|
|
Necrosis part, mean (%)
|
33% [min. 0–max. 87%]
|
|
Flair
|
114.9 cm3 ± 63.2
|
|
Histology
|
|
Glioblastoma-IDH wild type
|
46 (88.4%)
|
|
Glioblastoma IDH-mutated
|
3 (5.8%)
|
|
Gliosarcoma
|
3 (5.8%)
|
|
MGMTp methylation
|
|
Non-methylated
|
26 (50%)
|
|
Low methylation profile
|
2 (4%)
|
|
Methylated
|
12 (23%)
|
|
Unknown
|
12 (23%)
|
|
TERTp mutation
|
|
C228T
|
44 (84.6%)
|
|
C250T
|
1 (1.9%)
|
|
Wild-type (wt)
|
6 (11.6%)
|
|
Unknown
|
1 (1.9%)
|
